Aged
Aged, 80 and over
Humans
Lymphatic Irradiation
Male
Middle Aged
Neoplasm Staging
Pelvis
Prospective Studies
Prostatic Neoplasms
Radiotherapy Dosage
Survival Rate
Treatment Outcome
